# Research Proposal: Bayesian Neural Processes for Uncertainty Quantification in AI-Generated Scientific Hypotheses

## 1. Title

**Bayesian Neural Processes for Uncertainty Quantification in AI-Generated Scientific Hypotheses: A Staged Framework for Trustworthy Agentic AI in Scientific Discovery**

## 2. Introduction

### 2.1 Background

The emergence of agentic AI systems powered by foundation models has created unprecedented opportunities for scientific discovery. Systems like ChemCrow, Crispr-GPT, and SciAgents demonstrate the transformative potential of AI in generating novel scientific hypotheses across chemistry, biology, and materials science. However, a critical barrier prevents widespread adoption in high-stakes domains: the absence of reliable mechanisms to quantify the validity and confidence of AI-generated hypotheses before expensive experimental validation.

Current agentic AI systems generate hypotheses without principled uncertainty quantification, creating a "black box" problem where scientists cannot distinguish between high-confidence predictions warranting immediate experimental validation and speculative ideas requiring further refinement. This gap is particularly acute in domains like drug discovery and materials design, where failed experiments can waste months of effort and hundreds of thousands of dollars in resources. The inability to quantify epistemic uncertainty (knowledge gaps in the AI system) versus aleatoric uncertainty (inherent randomness in scientific phenomena) fundamentally limits trust and deployment.

Existing uncertainty quantification approaches—including Monte Carlo Dropout, Deep Ensembles, and temperature scaling—provide only post-hoc calibration without theoretical grounding in the hypothesis generation process. These methods cannot decompose uncertainty sources, provide interpretable confidence scores aligned with scientific reasoning, or guide targeted evidence collection to reduce uncertainty. Furthermore, they lack validation on scientific hypothesis datasets, having been developed primarily for classification and regression tasks.

Recent theoretical advances in Bayesian Neural Processes (BNPs) offer a promising solution. BNPs model functions as distributions, enabling principled epistemic uncertainty quantification through latent variable modeling. By treating hypothesis generation as a stochastic function mapping evidence and domain knowledge to validity scores, BNPs can decompose uncertainty, provide calibrated confidence intervals, and guide active learning for evidence acquisition. However, BNPs have never been applied to scientific hypothesis validation, and their effectiveness in this complex, multi-modal domain remains unexplored.

### 2.2 Research Objectives

This research proposes a staged Bayesian Neural Process framework to address the critical gap in uncertainty quantification for AI-generated scientific hypotheses. Our specific objectives are:

**Primary Objective:** Develop and validate a BNP-based system that reliably quantifies epistemic uncertainty in AI-generated scientific hypotheses, achieving calibration error below 15% and enabling 30%+ experimental cost savings through uncertainty-guided human escalation.

**Secondary Objectives:**

1. **Theoretical Contribution:** Establish the first formal application of Bayesian Neural Process theory to scientific hypothesis validation, providing mathematical foundations for epistemic/aleatoric uncertainty decomposition in scientific discovery contexts.

2. **Methodological Innovation:** Design multi-modal evidence encoders integrating scientific text (SciBERT), code (CodeBERT), and structured knowledge representations to capture diverse evidence types supporting hypothesis evaluation.

3. **Empirical Validation:** Conduct rigorous three-stage validation spanning retrospective analysis (500-1000 published papers), prospective expert evaluation (20 new hypotheses), and production deployment (50-100 real-world hypotheses).

4. **Practical Impact:** Demonstrate measurable cost savings (>30%) and improved resource allocation in scientific experimentation through uncertainty-guided selective validation.

### 2.3 Research Significance

This research addresses Gap 3 (P0 CRITICAL) identified in the workshop's call: formal verification and uncertainty quantification for agentic AI in science. The significance spans multiple dimensions:

**Theoretical Significance:** This work establishes the first rigorous probabilistic framework for hypothesis validity assessment, bridging Bayesian deep learning and philosophy of science. By formalizing hypothesis generation as a distribution over functions, we provide mathematical tools for reasoning about scientific uncertainty that extend beyond current ad-hoc approaches.

**Methodological Significance:** The proposed framework introduces novel techniques for multi-modal scientific evidence integration, decomposed uncertainty quantification across validity dimensions (novelty, testability, feasibility, impact), and active learning strategies for targeted evidence collection. These methods are generalizable across scientific domains.

**Practical Significance:** Enabling trustworthy deployment of agentic AI in high-stakes scientific domains directly addresses the workshop's focus on responsible AI for science. By reducing experimental costs by 30-50% while maintaining scientific rigor, this work demonstrates concrete value proposition for AI-human collaboration in research.

**Societal Significance:** Accelerating scientific discovery in critical domains like drug development and sustainable materials has profound implications for human health, environmental sustainability, and economic productivity. Trustworthy AI systems that scientists can confidently integrate into their workflows amplify human expertise rather than replacing it.

The research aligns with ICLR 2025 Workshop Thrust 2 (Theoretical Foundations) by developing statistical models for uncertainty quantification, and Thrust 4 (Open Problems) by addressing validation and reproducibility challenges through rigorous benchmarking on retrospective and prospective datasets.

## 3. Methodology

### 3.1 Theoretical Framework

#### 3.1.1 Bayesian Neural Process Formulation

We formalize scientific hypothesis validation as a meta-learning problem. Let $\mathcal{H}$ denote the space of scientific hypotheses, $\mathcal{E}$ the space of evidence (papers, experimental data, domain knowledge), and $\mathcal{V} = [0,1]$ the validity score space. Our goal is to learn a stochastic function $f: \mathcal{E} \times \mathcal{H} \rightarrow \mathcal{V}$ that maps evidence-hypothesis pairs to validity scores with calibrated uncertainty.

A Bayesian Neural Process models this function as a distribution over functions. Given a context set $\mathcal{C} = \{(e_i, h_i, v_i)\}_{i=1}^{n_c}$ of evidence-hypothesis-validity triples and a target hypothesis $h^*$ with evidence $e^*$, the BNP predicts:

$$p(v^* | e^*, h^*, \mathcal{C}) = \int p(v^* | e^*, h^*, z) p(z | \mathcal{C}) dz$$

where $z \in \mathbb{R}^{d_z}$ is a latent representation capturing global uncertainty about the hypothesis validation function.

The latent distribution is computed via:

$$p(z | \mathcal{C}) = \mathcal{N}(\mu_z, \Sigma_z)$$

$$\mu_z, \Sigma_z = \text{Aggregator}\left(\{h_\theta(e_i, h_i, v_i)\}_{i=1}^{n_c}\right)$$

where $h_\theta$ is a neural encoder and Aggregator is a permutation-invariant function (mean pooling or attention).

The predictive distribution is:

$$p(v^* | e^*, h^*, z) = \mathcal{N}(g_\phi(e^*, h^*, z), \sigma^2)$$

where $g_\phi$ is a decoder neural network.

#### 3.1.2 Epistemic Uncertainty Quantification

Epistemic uncertainty is quantified via the entropy of the latent distribution:

$$H[p(z|\mathcal{C})] = \frac{1}{2}\log\det(2\pi e \Sigma_z)$$

This measures uncertainty reducible through additional evidence. Aleatoric uncertainty is captured by $\sigma^2$ in the predictive distribution, representing irreducible randomness.

Total predictive uncertainty is:

$$\text{Var}[v^*] = \mathbb{E}_z[\text{Var}[v^*|z]] + \text{Var}_z[\mathbb{E}[v^*|z]]$$

where the first term is aleatoric and the second is epistemic.

#### 3.1.3 Calibration Objective

We optimize for calibration using Expected Calibration Error (ECE):

$$\text{ECE} = \sum_{m=1}^M \frac{|B_m|}{N} |\text{acc}(B_m) - \text{conf}(B_m)|$$

where $B_m$ are bins of predictions grouped by confidence, $\text{acc}(B_m)$ is empirical accuracy, and $\text{conf}(B_m)$ is average predicted confidence.

The training objective combines negative log-likelihood and calibration:

$$\mathcal{L} = -\mathbb{E}_{(e,h,v)\sim\mathcal{D}}[\log p(v|e,h,\mathcal{C})] + \lambda \cdot \text{ECE}$$

### 3.2 System Architecture

#### 3.2.1 Multi-Modal Evidence Encoder

The evidence encoder $h_\theta$ processes three modalities:

**Text Encoder:** Fine-tuned SciBERT processes hypothesis text and paper abstracts:
$$\mathbf{e}_{\text{text}} = \text{SciBERT}(\text{concat}(h_{\text{text}}, e_{\text{abstract}})) \in \mathbb{R}^{768}$$

**Code Encoder:** CodeBERT processes experimental protocols and computational methods:
$$\mathbf{e}_{\text{code}} = \text{CodeBERT}(e_{\text{methods}}) \in \mathbb{R}^{768}$$

**Knowledge Graph Encoder:** Graph neural network processes domain knowledge:
$$\mathbf{e}_{\text{kg}} = \text{GNN}(e_{\text{entities}}, e_{\text{relations}}) \in \mathbb{R}^{256}$$

These are fused via learned attention:

$$\mathbf{e} = \text{Attention}([\mathbf{e}_{\text{text}}, \mathbf{e}_{\text{code}}, \mathbf{e}_{\text{kg}}]) \in \mathbb{R}^{512}$$

#### 3.2.2 Decomposed Validity Prediction

We model four validity dimensions independently:

- **Novelty** ($v_n$): Hypothesis originality vs. existing literature
- **Testability** ($v_t$): Experimental feasibility and measurability
- **Feasibility** ($v_f$): Resource requirements and technical constraints
- **Impact** ($v_i$): Potential scientific significance

Each dimension has a separate BNP decoder:

$$p(v_d | e, h, z_d) = \mathcal{N}(g_{\phi_d}(e, h, z_d), \sigma_d^2), \quad d \in \{n, t, f, i\}$$

The overall validity score is a weighted combination:

$$v = \sum_{d} w_d \cdot v_d, \quad \sum_d w_d = 1$$

with weights $w_d$ learned during training or specified by domain experts.

### 3.3 Data Collection and Preparation

#### 3.3.1 Stage 1: Retrospective Dataset (Months 1-6)

**Dataset Construction:**

1. **Paper Selection:** Mine 500-1000 papers from ArXiv (cs.AI, q-bio, cond-mat) published 2015-2025
   - Inclusion criteria: Clear hypothesis statement in introduction, empirical validation in results
   - Domain distribution: 40% chemistry, 40% biology, 20% materials science
   - Publication tier diversity: 30% top-tier venues (Nature, Science, Cell), 70% domain journals

2. **Annotation Protocol:**
   - Extract hypothesis: Introduction section, identified via pattern matching ("we hypothesize", "we propose")
   - Extract evidence: Abstract, related work citations (up to 10 papers)
   - Extract validation outcome: Results section, binary classification (success/failure) based on:
     - Success: Main claims supported by experiments (p < 0.05 or domain-appropriate threshold)
     - Failure: Main claims refuted or inconclusive results
   - Graded annotation: 3 annotators per paper, majority vote for binary label, average for confidence score

3. **Bias Mitigation:**
   - Include 10% retracted papers (failure cases)
   - Include 15% papers from Negative Results journals
   - Balance success/failure ratio to 60/40

**Data Split:** Train 70% (n=350-700), Validation 15% (n=75-150), Test 15% (n=75-150)

**Quality Control:** Inter-annotator agreement (Cohen's kappa > 0.6), expert review of 10% sample

#### 3.3.2 Stage 2: Prospective Expert Validation (Months 7-12)

**Hypothesis Generation:**

1. Source 20 new hypotheses via:
   - 10 from Phase 2A agentic AI systems (ChemCrow-style)
   - 5 from recent preprints (arXiv, bioRxiv, posted within 3 months)
   - 5 from domain collaborators (unpublished ideas)

2. Domain distribution: 8 chemistry, 8 biology, 4 materials science

**Expert Panel:**

- Recruit 9 domain experts (3 per domain)
- Criteria: PhD + 5 years post-doctoral experience, h-index > 15
- Compensation: $200/hour, 2-4 hours per hypothesis

**Evaluation Protocol:**

1. Blind evaluation: Experts unaware of hypothesis source (AI vs. human)
2. Rating dimensions (1-5 Likert scale):
   - Novelty: "How original is this hypothesis?"
   - Testability: "How feasible is experimental validation?"
   - Feasibility: "What resources are required?"
   - Impact: "What is the potential scientific significance?"
3. Overall validity: Average of four dimensions, normalized to [0,1]
4. Confidence: "How confident are you in this assessment?" (1-5)

**Ground Truth:** Average expert rating per hypothesis, weighted by expert confidence

**Inter-Rater Reliability:** Fleiss' kappa (target > 0.6), discard hypotheses with kappa < 0.4

#### 3.3.3 Stage 3: Production Deployment (Months 13-18)

**Deployment Partner:** Collaborate with existing agentic AI system (ChemCrow-like or AutoLabs-like)

**Data Collection:**

1. Integrate BNP framework into hypothesis generation pipeline
2. Log for each hypothesis:
   - BNP confidence score and epistemic uncertainty
   - Escalation decision (auto-validate if confidence > 0.7, human review otherwise)
   - Validation outcome (experimental success/failure)
   - Resource costs (compute time, materials, human hours)

**Sample Size:** 50-100 hypotheses over 6 months

**Cost Tracking:**

- Baseline cost: All hypotheses undergo experimental validation
- BNP cost: High-confidence hypotheses auto-validated, low-confidence undergo expert review + selective validation
- Savings calculation:

$$\text{Savings} = \frac{C_{\text{baseline}} - C_{\text{BNP}}}{C_{\text{baseline}}} \times 100\%$$

where $C_{\text{BNP}} = C_{\text{high-conf-exp}} + C_{\text{expert-review}} + C_{\text{selective-exp}}$

### 3.4 Experimental Design

#### 3.4.1 Stage 1 Experiments

**Objective:** Validate BNP on retrospective dataset, establish baseline performance

**Architecture Variants:**

1. Standard Neural Process (NP)
2. Conditional Neural Process (CNP)
3. Attentive Neural Process (ANP)
4. Custom BNP with decomposed validity dimensions

**Training Procedure:**

1. Initialize encoders with pretrained weights (SciBERT, CodeBERT)
2. Train BNP end-to-end with Adam optimizer (lr=1e-4, batch size=16)
3. Context set size sampled uniformly: $n_c \sim \text{Uniform}(10, 50)$
4. Training epochs: 100, early stopping on validation ECE
5. Hyperparameter search: Grid search over latent dimension $d_z \in \{64, 96, 128\}$, evidence dimension $d \in \{256, 384, 512\}$

**Evaluation Metrics:**

- **Primary:** Expected Calibration Error (ECE) with 10 bins
- **Secondary:** 
  - Accuracy: Fraction of correct binary predictions (threshold=0.5)
  - AUROC: Area under ROC curve
  - Brier Score: $\frac{1}{N}\sum_{i=1}^N (v_i - \hat{v}_i)^2$
  - Negative Log-Likelihood (NLL)

**Success Criteria:** ECE < 20% AND Accuracy > 60% on test set

**Statistical Power:** With n=150 test samples, power=0.8 to detect ECE difference of 5% (α=0.05)

#### 3.4.2 Stage 2 Experiments

**Objective:** Prospective validation with domain experts, compare against baselines

**Baselines:**

1. **MC Dropout:** 50 forward passes with dropout rate 0.2
2. **Deep Ensemble:** 5 independently trained models
3. **Temperature Scaling:** Post-hoc calibration on validation set
4. **Gaussian Process:** RBF kernel on SciBERT embeddings
5. **Deterministic Baseline:** Single neural network without uncertainty

**Comparison Metrics:**

- Calibration error (ECE)
- Correlation with expert ratings (Pearson r, Spearman ρ)
- Uncertainty-failure correlation (Chi-square test)
- Computational cost (inference time, memory)

**Hypothesis Testing:**

- **H1:** BNP achieves lower ECE than all baselines (paired t-test, α=0.05)
- **H2:** BNP confidence correlates with expert validity (Pearson r > 0.6, p < 0.05)
- **H3:** High-uncertainty hypotheses (top quartile) have lower success rate than low-uncertainty (bottom quartile) (Chi-square, p < 0.05)

**Sample Size Justification:** With n=20 hypotheses, power=0.7 to detect correlation r=0.6 (α=0.05)

**Uncertainty Reduction Experiment:**

1. Select 5 high-uncertainty hypotheses (H > 5 bits)
2. Identify missing evidence via gradient-based attribution
3. Add 3-5 targeted evidence items (papers, experimental data)
4. Re-compute uncertainty, measure reduction percentage
5. Success: ≥30% reduction for ≥4/5 hypotheses

#### 3.4.3 Stage 3 Experiments

**Objective:** Production deployment, validate cost savings and calibration

**Deployment Protocol:**

1. Integrate BNP API into partner system
2. Set confidence threshold via ROC analysis on Stage 2 data (optimize F1 score)
3. Escalation policy:
   - Confidence > 0.7: Auto-validate (proceed to experiment)
   - Confidence 0.4-0.7: Expert review (5-10 min assessment)
   - Confidence < 0.4: Reject or request additional evidence

**Tracking System:**

- Log all hypotheses, confidence scores, decisions, outcomes
- Weekly calibration monitoring (rolling ECE on last 20 hypotheses)
- Monthly cost analysis

**Evaluation Metrics:**

- **Primary:** 
  - Calibration error (ECE < 15%)
  - Cost savings (> 30%)
- **Secondary:**
  - False positive rate (< 20%): Auto-validated hypotheses that fail
  - False negative rate (< 25%): Rejected hypotheses that would succeed
  - User satisfaction (Likert survey, target > 4/5)

**Success Criteria:** ECE < 15% AND Cost savings > 30% AND FPR < 20%

**Statistical Analysis:** Bootstrap confidence intervals (1000 samples) for cost savings estimate

### 3.5 Evaluation Metrics Summary

| Metric | Formula | Target | Stage |
|--------|---------|--------|-------|
| **ECE** | $\sum_{m=1}^{10} \frac{\|B_m\|}{N} \|\text{acc}(B_m) - \text{conf}(B_m)\|$ | <20% (S1), <15% (S3) | All |
| **Accuracy** | $\frac{1}{N}\sum_{i=1}^N \mathbb{1}[\hat{v}_i > 0.5 = v_i > 0.5]$ | >60% | S1 |
| **AUROC** | Area under ROC curve | >0.70 | S1 |
| **Brier Score** | $\frac{1}{N}\sum_{i=1}^N (v_i - \hat{v}_i)^2$ | <0.25 | S1 |
| **Correlation** | Pearson r between BNP confidence and expert rating | >0.6 | S2 |
| **Cost Savings** | $(C_{\text{baseline}} - C_{\text{BNP}})/C_{\text{baseline}}$ | >30% | S3 |
| **FPR** | False positives / Total auto-validated | <20% | S3 |
| **FNR** | False negatives / Total rejected | <25% | S3 |

## 4. Expected Outcomes & Impact

### 4.1 Expected Outcomes

#### 4.1.1 Theoretical Outcomes

1. **Formal Framework:** First rigorous probabilistic framework for scientific hypothesis validation, establishing mathematical foundations for epistemic uncertainty decomposition in discovery contexts. This includes:
   - Proof that BNP latent entropy bounds epistemic uncertainty
   - Calibration guarantees under distributional assumptions
   - Sample complexity bounds for achieving target ECE

2. **Uncertainty Taxonomy:** Formal decomposition of hypothesis uncertainty into:
   - Epistemic (reducible via evidence): Quantified by $H[p(z|\mathcal{C})]$
   - Aleatoric (irreducible randomness): Quantified by $\sigma^2$
   - Structural (model misspecification): Measured via ensemble disagreement

3. **Active Learning Theory:** Optimal evidence acquisition strategies for uncertainty reduction, including:
   - Information gain metrics for evidence selection
   - Convergence rates for uncertainty reduction with evidence

#### 4.1.2 Methodological Outcomes

1. **BNP Architecture:** Production-ready Bayesian Neural Process implementation with:
   - Multi-modal evidence encoder (text, code, knowledge graphs)
   - Decomposed validity prediction (novelty, testability, feasibility, impact)
   - Calibrated confidence scoring (ECE < 15%)
   - Interpretable uncertainty explanations

2. **Benchmark Dataset:** Community resource of 500-1000 annotated hypothesis-validation pairs spanning chemistry, biology, and materials science, enabling reproducible research on hypothesis evaluation

3. **Evaluation Protocol:** Standardized methodology for assessing hypothesis validation systems, including:
   - Retrospective evaluation on published papers
   - Prospective expert validation protocol
   - Production deployment metrics

4. **Integration Blueprint:** Reference architecture for incorporating uncertainty quantification into existing agentic AI systems (ChemCrow, SciAgents, etc.)

#### 4.1.3 Empirical Outcomes

Based on our three-stage validation plan, we expect:

**Stage 1 (Retrospective):**
- ECE: 15-20% (target: <20%)
- Accuracy: 62-68% (target: >60%)
- AUROC: 0.72-0.78 (target: >0.70)
- BNP outperforms baselines on 3/5 metrics

**Stage 2 (Prospective):**
- ECE: 18-22% (target: <20%)
- Expert correlation: r = 0.62-0.72 (target: >0.6)
- Uncertainty-failure correlation: χ² p < 0.01
- Evidence addition reduces uncertainty by 32-45% (target: >30%)

**Stage 3 (Production):**
- ECE: 12-18% (target: <15%)
- Cost savings: 32-48% (target: >30%)
- FPR: 15-22% (target: <20%)
- FNR: 18-28% (target: <25%)

### 4.2 Scientific Impact

#### 4.2.1 Advancing Agentic AI for Science

This research directly addresses the workshop's core mission of developing trustworthy agentic AI systems for scientific discovery. By providing the first theoretically-grounded uncertainty quantification framework, we enable:

1. **Trustworthy Deployment:** Scientists can confidently integrate AI-generated hypotheses into research workflows, knowing confidence scores are calibrated and interpretable

2. **Resource Optimization:** 30-50% experimental cost savings through selective validation of high-confidence predictions, accelerating discovery cycles

3. **Human-AI Collaboration:** Uncertainty-guided escalation enables optimal division of labor—AI handles high-confidence cases, humans focus on ambiguous or high-stakes decisions

4. **Reproducibility:** Standardized benchmarks and evaluation protocols enable rigorous comparison of hypothesis generation systems

#### 4.2.2 Broader Scientific Applications

The framework generalizes beyond initial domains (chemistry, biology, materials):

1. **Drug Discovery:** Prioritize compound synthesis based on predicted efficacy confidence, reducing failed trials
2. **Climate Science:** Assess confidence in climate model predictions, guide targeted data collection
3. **Particle Physics:** Evaluate new physics hypotheses before expensive collider experiments
4. **Astronomy:** Prioritize telescope observation targets based on discovery potential confidence

#### 4.2.3 Methodological Contributions to ML

1. **Bayesian Deep Learning:** Novel application of BNPs to structured prediction with multi-modal inputs, advancing meta-learning theory
2. **Calibration Research:** New techniques for achieving calibration in low-data regimes with expert feedback
3. **Active Learning:** Uncertainty-guided evidence acquisition strategies applicable beyond scientific discovery

### 4.3 Practical Impact

#### 4.3.1 Economic Impact

Assuming deployment across 100 research labs conducting 1000 hypothesis validations annually:

- Baseline cost per validation: $5,000 (materials, equipment, labor)
- Total baseline cost: $500M annually
- 35% cost savings via BNP: **$175M annual savings**
- Additional benefits: Faster time-to-discovery (20-30% reduction), increased research throughput

#### 4.3.2 Societal Impact

1. **Healthcare:** Accelerated drug discovery reduces time-to-market for life-saving therapies
2. **Sustainability:** Faster materials discovery enables renewable energy and carbon capture technologies
3. **Food Security:** Optimized agricultural research addresses global food challenges
4. **Education:** Transparent AI reasoning teaches scientific methodology to students

#### 4.3.3 Policy Impact

This research provides evidence-based foundations for:

1. **AI Governance:** Demonstrating how uncertainty quantification enables responsible AI deployment in high-stakes domains
2. **Research Funding:** Quantifying ROI of AI-augmented research justifies investment in agentic AI infrastructure
3. **Regulatory Frameworks:** Establishing standards for AI-generated scientific claims in regulatory submissions (FDA, EPA)

### 4.4 Limitations and Future Work

#### 4.4.1 Known Limitations

1. **Domain Specificity:** Initial validation focuses on chemistry, biology, materials; generalization to social sciences, mathematics requires adaptation
2. **Expert Dependence:** Stage 2-3 validation requires domain expert availability and agreement (kappa > 0.6)
3. **Publication Bias:** Retrospective dataset may over-represent successful hypotheses despite mitigation efforts
4. **Computational Cost:** BNP inference requires 2-5× more computation than deterministic baselines

#### 4.4.2 Future Research Directions

1. **Multi-Agent Extension:** Integrate BNP uncertainty into multi-agent scientific discovery systems (SciAgents-style)
2. **Continual Learning:** Update BNP models as new experimental results arrive, enabling lifelong learning
3. **Causal Reasoning:** Incorporate causal graphs to distinguish correlation from causation in hypothesis evaluation
4. **Automated Experimentation:** Close the loop by connecting BNP to robotic labs (AutoLabs), enabling fully autonomous discovery cycles
5. **Cross-Domain Transfer:** Investigate transfer learning from data-rich domains (chemistry) to data-scarce domains (materials)

### 4.5 Dissemination Plan

1. **Publications:**
   - Stage 1 results: ICLR 2026 (Bayesian deep learning track)
   - Stage 2-3 results: Nature Machine Intelligence or Science Robotics (AI for science)
   - Methodology paper: NeurIPS 2026 (datasets and benchmarks track)

2. **Open Source:**
   - Release BNP implementation (PyTorch, Apache 2.0 license)
   - Publish benchmark dataset (Hugging Face, CC-BY-4.0)
   - Provide integration examples for ChemCrow, SciAgents

3. **Community Engagement:**
   - Workshop tutorial at ICLR 2026 Agentic AI for Science
   - Webinar series for domain scientists (chemistry, biology, materials communities)
   - Collaboration with AI4Science initiatives (Microsoft Research, DeepMind)

4. **Industry Partnerships:**
   - Pilot deployments with pharmaceutical companies (Pfizer, Novartis)
   - Materials discovery collaborations (BASF, Dow Chemical)
   - Technology transfer via university licensing office

### 4.6 Success Metrics

The research will be considered successful if:

1. **Technical Success:** All three stages meet success criteria (ECE, accuracy, correlation, cost savings targets)
2. **Scientific Success:** ≥2 publications in top-tier venues (ICLR, NeurIPS, Nature family)
3. **Practical Success:** ≥1 industry deployment with documented cost savings
4. **Community Success:** ≥100 GitHub stars, ≥10 citations within 18 months of publication

This comprehensive framework positions Bayesian Neural Processes as the foundation for trustworthy, uncertainty-aware agentic AI in scientific discovery, directly addressing the workshop's mission while delivering measurable scientific, economic, and societal impact.